XML 73 R58.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Quarterly Results of Operations (unaudited) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Quarterly Financial Data [Abstract] |
Unaudited consolidated quarterly results of operations | The unaudited consolidated quarterly results of operations (in thousands, except per share data) were as follows:
| For the Three Months Ended
| December 31 |  | September 30 |  | June 30 |  | March 31
2024 |  |  |  |  |  |  |
Total revenue | $ | 646,542 |  |  | $ | 621,401 |  |  | $ | 647,145 |  |  | $ | 639,653 |
Total operating expenses | 665,138 |  | 637,669 |  | 639,357 |  | 653,062
Gain (loss) before preferred dividends and accretion of Series A Preferred Stock | (22,802) |  | (23,137) |  | 1,596 |  | (17,280)
Dividends and accretion of Series A Preferred Stock | (7,813) |  |  | (8,094) |  |  | (7,979) |  |  | (7,945) |
Net loss attributable to common shareholders of Evolent Health, Inc. | (30,615) |  | (31,231) |  |  | (6,383) |  |  | (25,225) |
Loss per common share |  |  |  |  |  |  |
Basic and diluted | $ | (0.27) |  |  | $ | (0.27) |  |  | $ | (0.06) |  |  | $ | (0.22) |
2023 |  |  |  |  |  |  |
Total revenue | $ | 556,055 |  |  | $ | 511,015 |  |  | $ | 469,136 |  |  | $ | 427,690 |
Total operating expenses | 577,405 |  | 528,953 |  | 490,704 |  | 438,045
Loss before preferred dividends and accretion of Series A Preferred Stock | (33,411) |  | (25,324) |  | (34,323) |  | (19,982)
Dividends and accretion of Series A Preferred Stock | (7,984) |  |  | (7,872) |  |  | (7,088) |  |  | (6,276) |
Net loss attributable to common shareholders of Evolent Health, Inc. | (41,395) |  | (33,196) |  | (41,411) |  | (26,258)
Loss per common share |  |  |  |  |  |  |
Basic and diluted | $ | (0.36) |  |  | $ | (0.30) |  |  | $ | (0.37) |  |  | $ | (0.24) |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialDataAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 270 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration